Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Alexis Michas

AddedMar 31, 2024

UpdatedMay 31, 2026

Alexis Michas

Alexis Michas

Board Member, Theragenics

Alexis Michas's Career

Theragenics

Buford, GA, US

Board Member· Board

AstroNova

West Warwick, RI, US

Board Member· Board

Revvity

Waltham, MA, US

Board Member· Board

BorgWarner

Auburn Hills, MI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Alexis Michas's Career

Theragenics

Public7501981Buford, GA, US

Board Member· Board

Leadership at Theragenics

George StoeckertBoard Member

Frank TaralloCEO

John RussellFounder

John V HerndonBoard Member

Peter A A SaundersBoard Member

Similar to Theragenics

Zenith Technical InnovationsGurnee, IL, USMedical Devicesest. 2014Zenith Technical InnovationsGurnee, IL, US · est. 2014

Zenith Technical Innovations: Illinois-based medical device manufacturer and distributor, specializing in versatile therapy solutions.

T.H.E. MedicalOwings Mills, MD, USMedical Devicesest. 2018T.H.E. MedicalOwings Mills, MD, US · est. 2018

T.H.E. Medical: A dedicated health and hygiene manufacturer for safe, comfortable patient transfers.

Series A · $3.8M75

ThermedicalWaltham, MA, USMedical Devicesest. 2008ThermedicalWaltham, MA, US · est. 2008

US-based Thermedical pioneers thermal ablation systems for advanced cancer and cardiac treatments.

Seed · $18.8M30

Integra LifeSciencesPrinceton, NJ, USImplants, Surgical Solutionsest. 1989Integra LifeSciencesPrinceton, NJ, US · est. 1989

US-based Integra LifeSciences provides surgical solutions and implants, specializing in orthopedics, neurosurgery, and wound repair.

Public · $350M3.7k

AstroNova

Public3941969West Warwick, RI, US

Board Member· Board

Leadership at AstroNova

Greg WoodsBoard Member

Dick WarzalaBoard Member

Mitch QuainBoard Member

Similar to AstroNova

Astra InnovationsHouston, TX, USAnalytics, Softwareest. 2018Astra InnovationsHouston, TX, US · est. 2018

Astra Innovations: Leading digital tech innovator offering powerful, user-friendly tools with real-time analytics.

Pre-Seed · $500k8

Astro DigitalSanta Clara, CA, USSatellite Data, Space Servicesest. 2014Astro DigitalSanta Clara, CA, US · est. 2014

Astro Digital: Global provider of micro-satellite systems, infrastructure, and space-based data services.

Series A · $16.6M25

AstroSan Francisco, CA, USWeb Developmentest. 2019AstroSan Francisco, CA, US · est. 2019

Astro: An open-source web development tool supporting multiple frameworks, simplifying website creation.

Foodspace TechnologyBoston, MA, USAnalytics, Dataest. 2018Foodspace TechnologyBoston, MA, US · est. 2018

Foodspace: AI tech transforming CPG labels into shopper-centric data for enhanced online discoverability.

Angel · $20k17

Revvity

Public16.7k2023Waltham, MA, US

Board Member· Board

Leadership at Revvity

Peter BarrettBoard Member

Samuel R. ChapinBoard Member

Prahlad R SinghCEO

Similar to Revvity

RevvityWaltham, MA, USLife Science Researchest. 1937RevvityWaltham, MA, US · est. 1937

PerkinElmer: A global leader in diagnostics, life science research, and industrial testing, operating in 190 countries.

Thermo Fisher thWaltham, MA, USLaboratory Products, Scientific Instrumentsest. 2006Thermo Fisher thWaltham, MA, US · est. 2006

Global provider of scientific instruments & consumables.

Public · $119B130k

FluidigmSouth San Francisco, CA, USBiotechnologyest. 1999FluidigmSouth San Francisco, CA, US · est. 1999

Standard BioTools Inc., based in South San Francisco, accelerates life sciences research with essential, standardized technologies.

ReviR TherapeuticsSan Francisco, CA, USMedicines, Therapeuticsest. 2021ReviR TherapeuticsSan Francisco, CA, US · est. 2021

ReviR Therapeutics: A genomics-based platform for developing innovative RNA-targeting medicines.

BorgWarner

Public$10.7M52.7k1928Auburn Hills, MI, US

Board Member· Board

Leadership at BorgWarner

David HaffnerBoard Member

Nelda J. ConnorsBoard Member

Thomas StallkampBoard Member

Deborah D. McWhinneyBoard Member

Frederic B. LissaldeBoard Member

Sara GreensteinBoard Member

People Similar to Alexis Michas

Lau Eng BoonBoard Member · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

Soemantri BrodjonegoroBoard Member · Bukalapak

WILL WEI CHENGBoard Member · DiDi

Dhirubhai H. AmbaniBoard Member · Reliance Retail

Mason YeoBoard Member · Kakao

JaeHong ChoiBoard Member · Kakao

Sean JohBoard Member · Kakao

James R. VerrierBoard Member · Parker-Hannifin

Bump WilliamsBoard Member · Riff

Frank WeberBoard Member · Daimler

Frédéric LissaldeCEO · BorgWarner